On the other hand, in the tumor microenvironment, hypoxic conditions (42), or soluble mediators such as PGE2 (43–45) and TGF-β (46) can induce NK cells to down-regulate expression and/or function of major activating NK receptors including NKp44. The gene discussed is NCR2; the disease is neoplasm.